These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. In vitro effects of cAMP-elevating agents and glucocorticoid either alone or in combination on the production of nitric oxide, interleukin-12 and interleukin-10 in IFN-gamma- and LPS-activated mouse peritoneal macrophages. Mittal J, Dogra N, Dass R, Majumdar S. Folia Microbiol (Praha); 2002 Jul 01; 47(6):709-16. PubMed ID: 12630324 [Abstract] [Full Text] [Related]
26. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages. Zhou R, Zheng SX, Tang W, He PL, Li XY, Yang YF, Li YC, Geng JG, Zuo JP. J Pharmacol Exp Ther; 2006 Jan 01; 316(1):121-8. PubMed ID: 16166270 [Abstract] [Full Text] [Related]
27. Inducible nitric oxide synthase knockout mouse macrophages disclose prooxidant effect of interferon-gamma on low-density lipoprotein oxidation. Niu XL, Xia Y, Hoshiai K, Tanaka K, Sawamura S, Nakazawa H. Nitric Oxide; 2000 Aug 01; 4(4):363-71. PubMed ID: 10944420 [Abstract] [Full Text] [Related]
28. Inhibition of lipopolysaccharide-stimulated nitric oxide production in RAW 264.7 macrophages by a synthetic carbazole, LCY-2-CHO. Tsao LT, Lee CY, Huang LJ, Kuo SC, Wang JP. Biochem Pharmacol; 2002 Jun 01; 63(11):1961-8. PubMed ID: 12093472 [Abstract] [Full Text] [Related]
29. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Suh N, Honda T, Finlay HJ, Barchowsky A, Williams C, Benoit NE, Xie QW, Nathan C, Gribble GW, Sporn MB. Cancer Res; 1998 Feb 15; 58(4):717-23. PubMed ID: 9485026 [Abstract] [Full Text] [Related]
33. Meconium induces expression of inducible NO synthase and activation of NF-kappaB in rat alveolar macrophages. Li YH, Yan ZQ, Brauner A, Tullus K. Pediatr Res; 2001 Jun 15; 49(6):820-5. PubMed ID: 11385144 [Abstract] [Full Text] [Related]
35. Regulation of the nitric oxide production resulting from the glucocorticoid-insensitive expression of iNOS in human osteoarthritic cartilage. Vuolteenaho K, Moilanen T, Al-Saffar N, Knowles RG, Moilanen E. Osteoarthritis Cartilage; 2001 Oct 15; 9(7):597-605. PubMed ID: 11597171 [Abstract] [Full Text] [Related]
36. Inhibition of lipopolysaccharide-induced nitric oxide production by flavonoids in RAW264.7 macrophages involves heme oxygenase-1. Lin HY, Juan SH, Shen SC, Hsu FL, Chen YC. Biochem Pharmacol; 2003 Nov 01; 66(9):1821-32. PubMed ID: 14563492 [Abstract] [Full Text] [Related]
37. Roles of tyrosine kinases in the regulation of nitric oxide synthesis in murine liver cells: modulation of NF-kappa B activity by tyrosine kinases. Lee BS, Kang HS, Pyun KH, Choi I. Hepatology; 1997 Apr 01; 25(4):913-9. PubMed ID: 9096597 [Abstract] [Full Text] [Related]
39. AVP inhibits LPS- and IL-1beta-stimulated NO and cGMP via V1 receptor in cultured rat mesangial cells. Umino T, Kusano E, Muto S, Akimoto T, Yanagiba S, Ono S, Amemiya M, Ando Y, Homma S, Ikeda U, Shimada K, Asano Y. Am J Physiol; 1999 Mar 01; 276(3):F433-41. PubMed ID: 10070167 [Abstract] [Full Text] [Related]
40. Osteopontin is induced by nitric oxide in RAW 264.7 cells. Takahashi F, Takahashi K, Maeda K, Tominaga S, Fukuchi Y. IUBMB Life; 2000 Mar 01; 49(3):217-21. PubMed ID: 10868913 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]